CS212304B2 - Method of making the salts of the 6,7-dihalogen-3,4-dihydro-3-oxo-chinxalin-carboxyl acids with defended amines - Google Patents
Method of making the salts of the 6,7-dihalogen-3,4-dihydro-3-oxo-chinxalin-carboxyl acids with defended amines Download PDFInfo
- Publication number
- CS212304B2 CS212304B2 CS807188A CS718880A CS212304B2 CS 212304 B2 CS212304 B2 CS 212304B2 CS 807188 A CS807188 A CS 807188A CS 718880 A CS718880 A CS 718880A CS 212304 B2 CS212304 B2 CS 212304B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- oxo
- dihydro
- carboxylic acid
- salt
- quinoxaline carboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/088,275 US4252954A (en) | 1979-10-25 | 1979-10-25 | Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS212304B2 true CS212304B2 (en) | 1982-03-26 |
Family
ID=22210429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS807188A CS212304B2 (en) | 1979-10-25 | 1980-10-23 | Method of making the salts of the 6,7-dihalogen-3,4-dihydro-3-oxo-chinxalin-carboxyl acids with defended amines |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4252954A (es) |
| EP (1) | EP0029658A1 (es) |
| JP (1) | JPS5681569A (es) |
| AU (1) | AU6351280A (es) |
| BE (1) | BE885793A (es) |
| CA (1) | CA1149381A (es) |
| CS (1) | CS212304B2 (es) |
| DD (1) | DD153689A5 (es) |
| DK (1) | DK449780A (es) |
| ES (1) | ES8205207A1 (es) |
| FI (1) | FI803294L (es) |
| FR (1) | FR2467848A1 (es) |
| GB (1) | GB2061936A (es) |
| GR (1) | GR69994B (es) |
| IL (1) | IL61313A0 (es) |
| IT (1) | IT1134009B (es) |
| PL (1) | PL227421A1 (es) |
| PT (1) | PT71939B (es) |
| YU (1) | YU268880A (es) |
| ZA (1) | ZA806437B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD281614A5 (de) * | 1988-09-02 | 1990-08-15 | Univ Berlin Humboldt | Verfahren zur herstellung von virostatisch wirksamendiazinsubstituierten 1-adamantanen |
| AU9049391A (en) * | 1990-12-20 | 1992-07-22 | Warner-Lambert Company | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity |
| US6348461B1 (en) * | 1997-09-01 | 2002-02-19 | Kyorin Pharmaceutical Co., Ltd. | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both |
| CA2520763A1 (en) * | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| JP2007532484A (ja) | 2004-03-16 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法 |
| WO2006045119A2 (en) * | 2004-10-20 | 2006-04-27 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| AR059826A1 (es) * | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
| US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| WO2012045280A1 (en) * | 2010-10-08 | 2012-04-12 | Novartis Ag | Salts and polymorphs of sulfamide ns3 inhibitors |
| JP6406159B2 (ja) | 2015-08-04 | 2018-10-17 | 株式会社デンソー | 車載表示制御装置、車載表示制御方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3355355A (en) * | 1965-02-05 | 1967-11-28 | Smith Kline French Lab | Antiviral cycloalkylamine compositions and method |
| DE1770697C3 (de) * | 1967-07-06 | 1981-04-23 | Dupher International Research B.V., Weesp | 2,2-(N-Methyl-2-azatetramethylen)- -adamantan, dessen Salze, Verfahren zu deren Herstellung und Arzneimittel |
| GB1438349A (en) * | 1973-09-13 | 1976-06-03 | Post Office | Conductor assemblies for cables |
| US4181724A (en) * | 1978-09-11 | 1980-01-01 | The Upjohn Company | Quinoxalinone compounds useful for expanding the lumina or air passages in mammals |
| PH15791A (en) * | 1978-10-20 | 1983-03-25 | Lilly Co Eli | Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines |
-
1979
- 1979-10-25 US US06/088,275 patent/US4252954A/en not_active Expired - Lifetime
-
1980
- 1980-10-20 PT PT71939A patent/PT71939B/pt unknown
- 1980-10-20 ZA ZA00806437A patent/ZA806437B/xx unknown
- 1980-10-20 FR FR8022412A patent/FR2467848A1/fr not_active Withdrawn
- 1980-10-20 CA CA000362726A patent/CA1149381A/en not_active Expired
- 1980-10-20 BE BE1/9993A patent/BE885793A/fr unknown
- 1980-10-20 IL IL61313A patent/IL61313A0/xx unknown
- 1980-10-20 FI FI803294A patent/FI803294L/fi not_active Application Discontinuation
- 1980-10-20 AU AU63512/80A patent/AU6351280A/en not_active Abandoned
- 1980-10-21 YU YU02688/80A patent/YU268880A/xx unknown
- 1980-10-21 PL PL22742180A patent/PL227421A1/xx unknown
- 1980-10-23 GR GR63209A patent/GR69994B/el unknown
- 1980-10-23 EP EP80303761A patent/EP0029658A1/en not_active Withdrawn
- 1980-10-23 IT IT25538/80A patent/IT1134009B/it active
- 1980-10-23 CS CS807188A patent/CS212304B2/cs unknown
- 1980-10-23 GB GB8034218A patent/GB2061936A/en not_active Withdrawn
- 1980-10-23 ES ES496210A patent/ES8205207A1/es not_active Expired
- 1980-10-24 JP JP15001480A patent/JPS5681569A/ja active Pending
- 1980-10-24 DD DD80224744A patent/DD153689A5/de unknown
- 1980-10-24 DK DK449780A patent/DK449780A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT71939B (en) | 1981-08-31 |
| ES496210A0 (es) | 1981-10-01 |
| PL227421A1 (es) | 1981-06-19 |
| JPS5681569A (en) | 1981-07-03 |
| IL61313A0 (en) | 1980-12-31 |
| PT71939A (en) | 1980-11-01 |
| IT8025538A0 (it) | 1980-10-23 |
| US4252954A (en) | 1981-02-24 |
| DK449780A (da) | 1981-04-26 |
| ES8205207A1 (es) | 1981-10-01 |
| AU6351280A (en) | 1981-04-30 |
| GR69994B (es) | 1982-07-23 |
| ZA806437B (en) | 1982-05-26 |
| DD153689A5 (de) | 1982-01-27 |
| YU268880A (en) | 1983-02-28 |
| GB2061936A (en) | 1981-05-20 |
| EP0029658A1 (en) | 1981-06-03 |
| FR2467848A1 (fr) | 1981-04-30 |
| BE885793A (fr) | 1981-04-21 |
| FI803294L (fi) | 1981-04-26 |
| CA1149381A (en) | 1983-07-05 |
| IT1134009B (it) | 1986-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102822171A (zh) | 作为自分泌运动因子抑制剂的苯并萘啶胺类 | |
| KR20140010012A (ko) | 글루코세레브로시다제 활성제로서 치환된 피라졸로피리미딘 | |
| SE406323B (sv) | Analogiforfarande for framstellning av 6,7-dihydrobensokinolizinkarboxylsyraderivat | |
| EP0129128A2 (de) | 2-Pyrimidinyl-l-piperazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| CZ153594A3 (en) | Therapeutically active substances | |
| CN110418796A (zh) | 托法替尼(tofacitinib)的葡萄糖苷酸前药 | |
| EP0516588B1 (de) | Substituierte Diaminophthalimide und Analoga | |
| US6737424B2 (en) | Alpha-substituted pyridazino quinoline compounds | |
| CS212304B2 (en) | Method of making the salts of the 6,7-dihalogen-3,4-dihydro-3-oxo-chinxalin-carboxyl acids with defended amines | |
| CA2622639C (en) | Hiv integrase inhibitors | |
| JP2006516653A (ja) | キナーゼ阻害剤ピロロトリアジンの製造方法 | |
| EP0647231A1 (de) | N-substituierte 3-azabicyclo 3.2.0]heptanderivate als neuroleptika usw. | |
| TW202021964A (zh) | 用於狂犬病之治療之化合物及其方法 | |
| CN102134234B (zh) | 吲唑脲类化合物及其制法和药物用途 | |
| UA57088C2 (uk) | Похідні 4-оксо-3,5-дигідро-4н-піридазино-[4,5-b]індол-1-ацетаміду, лікувальний засіб та фармацевтична композиція | |
| AU2114600A (en) | Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors | |
| CA2982862A1 (en) | Preparation and use of kinase inhibitor | |
| CN101514179A (zh) | 吲哚酮亚乙基肼羰基化合物、其制备方法及其在医药上的应用 | |
| CN106986874B (zh) | (1H-吡唑[3,4-d]嘧啶)-4-氨基衍生物及其作为IDO抑制剂在药物制备中的用途 | |
| JPH04128288A (ja) | キノロンカルボン酸誘導体及びその製造方法 | |
| CN107118209B (zh) | 吡啶骈[3,4-b]吲哚脲类化合物及其作为IDO抑制剂的用途 | |
| WO2019120258A1 (zh) | 苯并氮杂草衍生物、其制备方法及其在医药上的应用 | |
| EP0020836A1 (en) | Antiviral combinations | |
| DE3423003A1 (de) | Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| EA017630B1 (ru) | ЗАМЕЩЕННЫЕ 3-АРИЛСУЛЬФОНИЛПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT-РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |